Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 tax-1 function and inhibits viral replication

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10719-10729

  Tosi, Giovanna ^a   Forlani, Greta ^a   Andresen, Vibeke ^b,e   Turci, Marco ^c   Bertazzoni, Umberto ^c   Franchini, Genoveffa ^b   Poli, Guido ^d   Accolla, Roberto S ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VERONA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2 TRANSACTIVATOR CIITA; NUCLEAR FACTOR Y; TAX PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL STRAIN HEK293; CELL STRAIN U937; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IN VIVO STUDY; INHIBITION KINETICS; LONG TERMINAL REPEAT; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE PRODUCTS, TAX; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MONOCYTES; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; TRANS-ACTIVATORS; VIRUS REPLICATION;

HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 80054996890     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00813-11     Document Type: Article

References (54)

1. Accolla, R. S., et al. 1986. Air-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. Exp. Med. 164:369-374.
2. Accolla, R. S., et al. 2001. The MHC class II transactivator: prey and hunter in infectious diseases. Trends Immunol. 22:560-563.
3. Accolla, R. S., S. Mazza, A. De Lerma Barbaro, A. De Maria, and G. Tosi. 2002. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication. Eur. J. Immunol. 32:2783-2791.
4. Alfano, M., C. Rizzi, G. Poli, and P. Biswas. 2007. HIV-1 infection of promonocytic U937 and U1 cell lines: clonal distribution of innate restriction factors, p. 89-113. In G. Herbein (ed.), HIV and the macrophage. Transworld Research Network, Kerala, India.
5. Boxus, M., et al. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76-99.
6. Calattini, S., et al. 2005. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in central Africa. Retrovirology 2:30-33.
7. Casoli, C., et al. 2004. The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2. Blood 103:995-1001.
8. Chiu, Y., and W. Greene. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-353.
9. Cressman, D. E., W. J. O'Connor, S. F. Greer, X. S. Zhu, and J. P. Y. Ting. 2001. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. J. Immunol. 167:3626-3634.
10. De Sandro, A. M., U. M. Nagarajan, and J. M. Boss. 2000. Associations and interactions between bare lymphocyte syndrome factors. Mol. Cell. Biol. 20:6587-6599.
11. Feuer, G., and P. L. Green. 2005. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24:5996-6004.
12. Fontes, J. D., S. Kanazawa, N. Nekrep, and B. M. Peterlin. 1999. The class II transactivator CIITA is a transcriptional integrator. Microbes Infect. 1:863-869.
13. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
14. Franzoso, G., et al. 1994. A family of serine proteases expressed exclusively in myelomonocytic cells specifically processes the nuclear factor-B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells. J. Exp. Med. 180:1445-1456.
15. Georges, S. A., et al. 2003. Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent. Mol. Cell. Biol. 23:3392-3404.
16. Goren, I., O. J. Semmes, K. T. Jeang, and K. Moelling. 1995. The amino terminus of Tax is required for interaction with the cyclic AMP response element binding protein. J. Virol. 69:5806-5811.
17. Grassmann, R. C., et al. 1989. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. U. S. A. 86:3351-3355.
18. Greer, S. F., E. Zika, B. Conti, X. S. Zhu, and J. P. Y. Ting. 2003. Enhancement of CIITA transcriptional function by ubiquitin. Nature Immunol. 4:1074-1082.
19. Hall, W. W., and M. Fujii. 2005. Deregulation of cell-signaling pathways in HTLV-1 infection. Oncogene 24:5965-5975.
20. Harrod, R., et al. 1998. An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18:5052-5061.
21. Harrod, R., et al. 2000. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type 1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J. Biol. Chem. 16:11852-11857.
22. Hemelaar, J., et al. 2001. Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity. J. Virol. 75:11106-11115.
23. Hoffman, P. M., et al. 1992. Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures. Proc. Natl. Acad. Sci. U. S. A. 89:1845-1849.
24. Jabrane-Ferrat, N., N. Nekrep, G. Tosi, L. Esserman, and B. M. Peterlin. 2003. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators? Int. Immunol. 15:467-475.
25. Jiang, H., et al. 1999. PCAF interacts with Tax and stimulates Tax transactivation in a histone acetyltransferase-independent manner. Mol. Cell. Biol. 19:8136-8145.
26. Kajaste-Rudnitski, A., et al. 2011. TRIM22 inhibits HIV-1 transcription independently of its E3-ubiquitin ligase activity, Tat, and NF-B responsive LTR elements. J. Virol. 85:5183-5196.
27. Kalyanaraman, V. S., et al. 1982. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571-573.
28. Kashanchi, F., et al. 1998. The coactivator CBP stimulates human T-cell lymphotropic virus type I Tax transactivation in vitro. J. Biol. Chem. 51: 34646-34652.
29. Kimata, J. T., F. H. Wong, J. J. Wang, and L. Ratner. 1994. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology 204:656-664.
30. Kretsovali, A., et al. 1998. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:6777-6783.
31. Kretsovali, A., C. Spilianakis, A. Dimakopoulos, T. Makatounakis, and J. Papamatheakis. 2001. Self-association of class II transactivator correlates with its intracellular localization and transactivation. J. Biol. Chem. 276: 32191-32197.
32. Kwok, R. P., et al. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the coactivator CBP. Nature 380:642-646.
33. Lehky, T. J., et al. 1996. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles. Ann. Neurol. 40:714-723.
34. Mahieux, R., and A. Gessain. 2003. HTLV-1 and associated adult T cell leukemia/lymphoma. Rev. Clin. Exp. Hematol. 7:336-361.
35. Masternak, K., et al. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14:1156-1166.
36. Matsuoka, M., and K. T. Jeang. 2007. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7:270-280.
37. Ozato, K., D. Shin, T. Chang, and H. C. Morse, III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-860.
38. Paskalis, H., B. K. Felber, and G. N. Pavlakis. 1986. cis-Acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type 1 constitute a conditional enhancer. Proc. Natl. Acad. Sci. U. S. A. 83:6558-6562.
39. Pise-Masison, C. A., J. Dittmer, K. E. Clemens, and J. N. Brady. 1997. Physical and functional interaction between the human T-cell lymphotropic virus type I Tax1 protein and the CCAAT binding protein NF-Y. Mol. Cell. Biol. 17:1236-1243.
40. Poiesz, B. J., et al. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77:7415-7419.
41. Roucoux, D. F., and E. L. Murphy. 2004. The epidemiology and disease outcomes of human T-lymphotropic virus type II. AIDS Rev. 6:144-154.
42. Sheehy, A., N. Gaddis, J. Choi, and M. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
43. Sisk, T. J., T. Gourley, S. Roys, and C.-H. Chang. 2000. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J. Immunol. 165: 2511-2517.
44. Smith, M. R., and W. C. Green. 1990. Identification of HTLV-1 Tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
45. Spilianakis, C., J. Papamatheakis, and A. Kretsovali. 2000. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol. Cell. Biol. 20:8489-8498.
46. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146.
47. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
48. Tosi, G., N. Jabrane-Ferrat, and B. M. Peterlin. 2002. Phosphorylation of CIITA directs its oligomerization, accumulation, and increased activity on MHC-II promoters. EMBO J. 21:5467-5476.
49. Tosi, G., et al. 2006. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y. Proc. Natl. Acad. Sci. U. S. A. 103:12861-12866.
50. Tosi, G., L. Bozzo, and R. S. Accolla. 2009. The dual function of the MHC class II transactivator CIITA against HTLV retroviruses. Front. Biosci. 14: 4149-4156.
51. Uchiyama, T. 1997. Human T-cell leukemia virus type 1 (HTLV-1) and human diseases. Annu. Rev. Immunol. 15:15-37.
52. Wolfe, N. D., et al. 2005. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc. Natl. Acad. Sci. U. S. A. 102:7994-7999.
53. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U. S. A. 79:2031-2035.
54. Zhu, X. S., and J. P. Y. Ting. 2001. A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen α(2)(I) and other promoters. Mol. Cell. Biol. 21: 7078-7088.